Historically, screening has relied almost entirely on conventional visual inspection and tactile palpation—methods burdened by significant inter-examiner variability and subjective clinical interpretation.
The integration of Artificial Intelligence (AI) and deep learning into clinical stomatology is rapidly transforming this diagnostic paradigm.
Rather than operating as an isolated computational tool, machine learning algorithms are evolving into robust Clinical Decision Support Systems (CDSS).
From Convolutional Neural Networks (CNNs) trained to detect early dysplastic alterations in mucosal photographs to whole-slide digital histopathology and radiomic CBCT segmentation, AI is bridging the critical gap between chairside clinical suspicion and definitive surgical intervention.
Key Clinical Insights & Applications for the Clinician
✔ Mucosal Screening & Computer Vision (CNNs)
Advanced deep learning architectures trained on intraoral photographic datasets, autofluorescence images, and Narrow-Band Imaging (NBI) are demonstrating high sensitivity in triaging oral leukoplakia, erythroplakia, and early Oral Squamous Cell Carcinoma (OSCC).
These algorithms assist general dentists in identifying suspicious margins and reducing diagnostic referral delays.
✔ Whole-Slide Imaging (WSI) & Computational Histopathology
In the pathology laboratory, automated digital slide scanners powered by AI quantify nuclear-to-cytoplasmic ratios, cellular pleomorphism, epithelial dysplasia grading, and Tumor-Infiltrating Lymphocytes (TILs).
This provides standardized objective metrics that minimize inter-observer discrepancies among oral pathologists.
✔ Radiomics in Maxillofacial Lesions
Deep learning models applied to panoramic radiographs and Cone Beam Computed Tomography (CBCT) demonstrate remarkable accuracy in segmenting and differentiating benign yet locally aggressive lesions—such as ameloblastomas and Odontogenic Keratocysts (OKCs)—from non-neoplastic cystic entities, streamlining preoperative surgical planning.
✔ Interdisciplinary Triage & Clinical Governance
AI does not replace histopathological tissue biopsy, which remains the uncompromised gold standard.
Instead, it functions as an intelligent triage filter, ensuring that suspicious, asymptomatic micro-lesions are flagged and referred before progressing to advanced stages.
Conclusion
Never consider artificial intelligence as a substitute for biopsy and microscopic confirmation.
AI is an adjunct screening tool designed to heighten clinical suspicion and standardize risk stratification.
The definitive diagnosis of any mucosal, fibro-osseous, or odontogenic pathology will always rely on thorough clinical correlation, advanced imaging, and expert histopathological analysis!
